Authorized SARS-CoV-2 molecular methods show wide variability in the limit of detection.

On February 29(th), 2020, the U.S. Food and Drug Administration issued the first Emergency Use Authorization (EUA) for a SARS-CoV-2 assay outside of the U.S. Centers for Disease Control and Prevention. As of May 3(rd), 2021, 289 total EUAs have been granted. Like influenza, there is no standard for...

Descripción completa

Detalles Bibliográficos
Autores principales: Blommel, Joseph H., Jenkinson, Garrett, Binnicker, Matthew J., Karon, Brad S., Boccuto, Luigi, Ivankovic, Diana S., Sarasua, Sara M., Kipp, Benjamin R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751006/
https://www.ncbi.nlm.nih.gov/pubmed/36669396
http://dx.doi.org/10.1016/j.diagmicrobio.2022.115880

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751006/
https://www.ncbi.nlm.nih.gov/pubmed/36669396
http://dx.doi.org/10.1016/j.diagmicrobio.2022.115880

Ejemplares similares